Carlsmed (CARL) Revenue (2024 - 2026)

Carlsmed (CARL) has 3 years of Revenue data on file, last reported at $16.1 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 58.17% year-over-year to $16.1 million; the trailing twelve-month figure through Mar 2026 stood at $56.4 million (up 74.9% YoY), and the FY2025 full-year result was $50.5 million, up 85.94% from the prior year.
• Revenue for Q1 2026 stood at $16.1 million, up from $15.2 million in the prior quarter.
• Across five years, Revenue topped out at $16.1 million in Q1 2026 and bottomed at $6.1 million in Q2 2024.
• The 3-year median for Revenue is $11.1 million (2025), against an average of $11.1 million.
• The widest annual swing landed in 2025, when Revenue jumped 98.7%; it then soared 58.17% in 2026.
• A 3-year view of Revenue shows it stood at $9.4 million in 2024, then soared by 61.19% to $15.2 million in 2025, then increased by 6.27% to $16.1 million in 2026.
• The last three Revenue figures came in at $16.1 million (Q1 2026), $15.2 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.

Peer Comparison